Indegene

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE065X01017
NSEID: INDGN
BSEID: 544172

INR

526.40

-5.35 (-1.01%)

BSENSE

Dec 12

BSE+NSE Vol: 2.15 lacs

{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "526.40",
    "chg": -5.35,
    "chgp": "-1.01%",
    "dir": -1,
    "prev_price": "531.75",
    "mcapval": "12,800.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "",
    "isin": "INE065X01017",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "2.15 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indegene-10039241-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indegene Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-technical-momentum-shifts-amid-mixed-market-returns-3740490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Indegene_technicaldot_3740490.png",
        "date": "2025-12-02 08:13:35",
        "description": "Indegene, a key player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a subtle change in the stock’s price dynamics, with technical indicators such as MACD, RSI, and moving averages offering a mixed perspective on its near-term trajectory."
      },
      {
        "title": "Indegene Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-technical-momentum-shifts-amid-bearish-signals-despite-short-term-gains-3730388",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_technicaldot_3730388.png",
        "date": "2025-11-26 08:11:20",
        "description": "Indegene, a key player in the Healthcare Services sector, is currently exhibiting a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent evaluation adjustments highlight a transition in market assessment, with technical indicators such as MACD, RSI, and moving averages providing a mixed outlook for investors navigating this small-cap stock."
      },
      {
        "title": "Indegene’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-3727986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_mojoScore_3727986.png",
        "date": "2025-11-25 09:03:10",
        "description": "Indegene, a key player in the Healthcare Services sector, has undergone a revision in its market evaluation following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite flat quarterly financial results and subdued stock returns over the past year, shifts in technical patterns and institutional interest have influenced the overall market perspective on the company."
      },
      {
        "title": "Indegene Shows Mixed Technical Signals Amidst Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-technical-momentum-shifts-amid-mixed-market-signals-3727740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_technicaldot_3727740.png",
        "date": "2025-11-25 08:15:46",
        "description": "Indegene, a key player in the Healthcare Services sector, is exhibiting a complex blend of technical indicators that reflect a nuanced price momentum shift. Recent market data reveals a transition in technical trends, with some signals pointing towards cautious optimism while others suggest ongoing challenges in the stock’s trajectory."
      },
      {
        "title": "How has been the historical performance of Indegene?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indegene-3726464",
        "imagepath": "",
        "date": "2025-11-24 23:31:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth Trajectory</strong></p>\n<p>Indegene’s net sales have shown a robust upward trajectory, increasing from ₹1,664.61 crores in March 2022 to ₹2,839.30 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 27.5%, reflecting strong demand and effective business expansion strategies. Total operating income mirrors this trend, as other operating income remained nil throughout the period.</p>\n<p>Operating profit before depreciation and interest (PBDIT excluding other income) rose steadily from ₹286.92 crores in 2022 to ₹534.30 crores in 2025, indicating improved operational efficiency. When factoring in other income, operating profit (PBDIT) increased from ₹312.81 crores to ₹641.50 crores over the same period. This growth was accompanied..."
      },
      {
        "title": "Why is Indegene falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indegene-fallingrising-3687439",
        "imagepath": "",
        "date": "2025-11-11 00:24:02",
        "description": "As of 10-Nov, Indegene Ltd's stock price is currently at 518.15, reflecting a decrease of 5.0, or 0.96%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.76% during this period. Additionally, the stock has shown a significant negative performance over various time frames, with a year-to-date decline of 14.21% and a one-year drop of 24.77%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a Price to Book Value of 0.4, the company's recent quarterly results showed a decline in profit after tax, which may have contributed to the stock's downward movement. Furthermore, while institutional investors have increased their stake by 7.05%, the overall sentiment remains cautious due to the stock's underperformance compared to broader market indices.\n\nIn the broader market context, Indegene's short-term performance has..."
      },
      {
        "title": "Indegene Experiences Technical Trend Shift Amidst Bearish Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegenes-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-declining-stock-performance-3678744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Indegene_technicaldot_3678744.png",
        "date": "2025-11-07 08:10:41",
        "description": "Indegene, a small-cap healthcare services company, is experiencing a bearish trend in its stock performance, currently priced at 530.10. The stock has underperformed against the Sensex over various time frames, with notable declines in weekly, monthly, and yearly returns, reflecting ongoing market challenges."
      },
      {
        "title": "How has been the historical performance of Indegene?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indegene-3668329",
        "imagepath": "",
        "date": "2025-11-03 22:59:54",
        "description": "Answer:\nIndegene has shown a consistent growth trajectory in its financial performance over the past four years, with net sales increasing from 1,664.61 Cr in Mar'22 to 2,839.30 Cr in Mar'25. Total operating income has mirrored this growth, rising from 1,664.61 Cr in Mar'22 to 2,839.30 Cr in Mar'25. The company's operating profit (PBDIT) has also improved significantly, from 312.81 Cr in Mar'22 to 641.50 Cr in Mar'25, indicating a strong operational efficiency. Profit before tax has followed suit, climbing from 226.50 Cr in Mar'22 to 539.30 Cr in Mar'25, while profit after tax has reached 406.70 Cr in Mar'25, up from 162.82 Cr in Mar'22. The earnings per share (EPS) have increased from 7.47 in Mar'22 to 16.98 in Mar'25, reflecting enhanced shareholder value. On the balance sheet, total assets have grown from 1,284.31 Cr in Mar'22 to 3,236.10 Cr in Mar'25, with total liabilities also increasing from 1,284.31..."
      },
      {
        "title": "Are Indegene latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indegene-latest-results-good-or-bad-3662402",
        "imagepath": "",
        "date": "2025-10-31 19:19:10",
        "description": "Indegene's latest financial results for Q2 FY26 reveal a complex operational landscape. The company achieved record quarterly revenues of ₹804.20 crores, reflecting a year-on-year growth of 17.09% and a sequential increase of 5.70%. This robust revenue growth indicates strong traction in the healthcare services market. However, the results also highlight significant challenges, particularly in profitability and operational efficiency.\n\nNet profit for the quarter was ₹102.10 crores, which represents a sequential decline of 12.29% from the previous quarter. This decline breaks the positive momentum observed in earlier periods, raising concerns about the company’s ability to sustain profitability amidst rising costs. The operating margin also contracted sharply to 17.48%, down from 20.41% in the previous quarter, indicating margin compression despite the revenue growth. The increase in employee costs, which ro..."
      }
    ],
    "total": 167,
    "sid": "10039241",
    "stock_news_url": "https://www.marketsmojo.com/news/indegene-10039241"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>100%</strong> dividend, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indegene Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:13:35

Indegene, a key player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent market data reveals a subtle change in the stock’s price dynamics, with technical indicators such as MACD, RSI, and moving averages offering a mixed perspective on its near-term trajectory.

Indegene Technical Momentum Shifts Amid Mixed Market Signals

2025-11-26 08:11:20

Indegene, a key player in the Healthcare Services sector, is currently exhibiting a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent evaluation adjustments highlight a transition in market assessment, with technical indicators such as MACD, RSI, and moving averages providing a mixed outlook for investors navigating this small-cap stock.

Indegene’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts

2025-11-25 09:03:10

Indegene, a key player in the Healthcare Services sector, has undergone a revision in its market evaluation following a detailed analysis of its quality, valuation, financial trends, and technical indicators. Despite flat quarterly financial results and subdued stock returns over the past year, shifts in technical patterns and institutional interest have influenced the overall market perspective on the company.

Indegene Shows Mixed Technical Signals Amidst Market Volatility

2025-11-25 08:15:46

Indegene, a key player in the Healthcare Services sector, is exhibiting a complex blend of technical indicators that reflect a nuanced price momentum shift. Recent market data reveals a transition in technical trends, with some signals pointing towards cautious optimism while others suggest ongoing challenges in the stock’s trajectory.

How has been the historical performance of Indegene?

2025-11-24 23:31:13

Revenue and Profit Growth Trajectory

Indegene’s net sales have shown a robust upward trajectory, increasing from ₹1,664.61 crores in March 2022 to ₹2,839.30 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 27.5%, reflecting strong demand and effective business expansion strategies. Total operating income mirrors this trend, as other operating income remained nil throughout the period.

Operating profit before depreciation and interest (PBDIT excluding other income) rose steadily from ₹286.92 crores in 2022 to ₹534.30 crores in 2025, indicating improved operational efficiency. When factoring in other income, operating profit (PBDIT) increased from ₹312.81 crores to ₹641.50 crores over the same period. This growth was accompanied...

Why is Indegene falling/rising?

2025-11-11 00:24:02

As of 10-Nov, Indegene Ltd's stock price is currently at 518.15, reflecting a decrease of 5.0, or 0.96%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 3.76% during this period. Additionally, the stock has shown a significant negative performance over various time frames, with a year-to-date decline of 14.21% and a one-year drop of 24.77%. Despite a low debt-to-equity ratio and an attractive valuation indicated by a Price to Book Value of 0.4, the company's recent quarterly results showed a decline in profit after tax, which may have contributed to the stock's downward movement. Furthermore, while institutional investors have increased their stake by 7.05%, the overall sentiment remains cautious due to the stock's underperformance compared to broader market indices. In the broader market context, Indegene's short-term performance has...

Indegene Experiences Technical Trend Shift Amidst Bearish Market Sentiment

2025-11-07 08:10:41

Indegene, a small-cap healthcare services company, is experiencing a bearish trend in its stock performance, currently priced at 530.10. The stock has underperformed against the Sensex over various time frames, with notable declines in weekly, monthly, and yearly returns, reflecting ongoing market challenges.

How has been the historical performance of Indegene?

2025-11-03 22:59:54

Answer: Indegene has shown a consistent growth trajectory in its financial performance over the past four years, with net sales increasing from 1,664.61 Cr in Mar'22 to 2,839.30 Cr in Mar'25. Total operating income has mirrored this growth, rising from 1,664.61 Cr in Mar'22 to 2,839.30 Cr in Mar'25. The company's operating profit (PBDIT) has also improved significantly, from 312.81 Cr in Mar'22 to 641.50 Cr in Mar'25, indicating a strong operational efficiency. Profit before tax has followed suit, climbing from 226.50 Cr in Mar'22 to 539.30 Cr in Mar'25, while profit after tax has reached 406.70 Cr in Mar'25, up from 162.82 Cr in Mar'22. The earnings per share (EPS) have increased from 7.47 in Mar'22 to 16.98 in Mar'25, reflecting enhanced shareholder value. On the balance sheet, total assets have grown from 1,284.31 Cr in Mar'22 to 3,236.10 Cr in Mar'25, with total liabilities also increasing from 1,284.31...

Are Indegene latest results good or bad?

2025-10-31 19:19:10

Indegene's latest financial results for Q2 FY26 reveal a complex operational landscape. The company achieved record quarterly revenues of ₹804.20 crores, reflecting a year-on-year growth of 17.09% and a sequential increase of 5.70%. This robust revenue growth indicates strong traction in the healthcare services market. However, the results also highlight significant challenges, particularly in profitability and operational efficiency. Net profit for the quarter was ₹102.10 crores, which represents a sequential decline of 12.29% from the previous quarter. This decline breaks the positive momentum observed in earlier periods, raising concerns about the company’s ability to sustain profitability amidst rising costs. The operating margin also contracted sharply to 17.48%, down from 20.41% in the previous quarter, indicating margin compression despite the revenue growth. The increase in employee costs, which ro...

View All News